Is It Too Early to Crosslink in the Pediatric Population for Keratoconus? | ASCRS

Alert

Registration Deadline Sunday


Register for the Annual Meeting, taking place in San Diego, May 5–8! The price to attend goes up after Sunday, April 2.

Menu
Home Clinical Education Cornea Is It Too Early to Crosslink in the Pediatric Population for Keratoconus?
Presentation
Is It Too Early to Crosslink in the Pediatric Population for Keratoconus?
April 2022
Meeting: 2022 ASCRS Annual Meeting
Session: SYM-8 Management Pearls on Challenging Corneal Diseases
Presenter: Maria S. Cortina, MD, ABO
This content is only available to 2022 ASCRS Annual Meeting physician registrants

To log in, click the teal "Login" button in the upper right-hand corner of this page. If you are logged in but still do not have access, please check your 2022 Annual Meeting registration.

Filed Under
Cornea keratoconus crosslinking pediatric
View More Presentations from SYM-8

This presentation is from the session "SYM-8 Management Pearls on Challenging Corneal Diseases" from the 2022 ASCRS Annual Meeting held on April 22-26, 2022 in Washington, DC.

View More From This Session
Browse All 2022 ASCRS On Demand Sessions

Related Content

Video
Successful DALK with the Aid of Femtosecond Laser and Pachymetry Guided Double Bubble: A Step By Step Approach
Producer: Eric Oregon Miranda, MD 07:57 minutes
May 2019
Session
IC-209 Two Decades of Corneal Cross-Linking: Current Indications, Applications, Outcomes, and Complications-Management; The US, FDA-Approved Technique and Evolving Technology and Techniques
July 2021
Presentation
When to Repeat Collagen Crosslinking?
Julie Schallhorn, MD 08:02 minutes
April 2022
Presentation
Crosslinking and Intacs: What Are the Best Practices and How Do I Start Incorporating into My Practice?
A. John Kanellopoulos, MD, ABO 12:40 minutes
April 2022
American
About ASCRS
Clinical Education
Meetings
Tools
ASCRS foundation
Donate
Contact Us

© 2023 ASCRS. All Rights Reserved.

Advertise Legal Notice

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.